Danielle Rapaccioli

Davis Polk advised PPL Capital Funding, Inc. on its registered offering of $1.0 billion aggregate principal amount of 4.125% senior notes due 2030, fully and unconditionally guaranteed by…

Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Atara Biotherapeutics, Inc. of its common stock for up to an aggregate amount of $100 million. Based in…

Davis Polk advised the joint bookrunners in connection with a primary offering by BR Properties S.A. of common shares for an aggregate amount of R$1.05 billion (approximately US$247.5…

Davis Polk advised the joint bookrunners in connection with the initial public offering by C&A Modas S.A. and the selling shareholders of 98,630,146 common shares for an aggregate…

Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 2,303,030 shares of its common stock. The common stock is listed on the…

Davis Polk advised the underwriters in connection with an SEC-registered offering by The Hartford Financial Services Group, Inc. of $600 million aggregate principal amount of its 2.800%…

Davis Polk advised the representatives of the underwriters in connection with the $104.7 million initial public offering of 6,543,500 shares of common stock of TransMedics Group, Inc.,…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering of senior notes by Ingersoll-Rand Luxembourg…

Davis Polk advised the sales agents in connection with the establishment of an SEC-registered at-the-market offering program by MDU Resources Group, Inc. of up to 10,000,000 shares of…

Davis Polk advised the underwriters in connection with an SEC-registered offering by Weyerhaeuser Company of $750 million aggregate principal amount of its 4.00% senior notes due 2029…